Rivian has made plenty of good decisions, but this one might top them all.

Eli Lilly lost the momentum it had during the first half of the year. However, the company still has plenty of long-term ...

On Nov. 20, Nvidia reported financial results for its fiscal 2025 third quarter, showing stunning 94% year-over-year revenue ...

Costco stock is as expensive as it's ever been, making a pullback a very real near-term possibility. There's one specific ...

Lucid's historical trend of disappointing deliveries has reversed in a big way. Lucid has posted three consecutive quarters ...

Numerous growth drivers and strong tailwinds should combine to drive this artificial intelligence (AI) pioneer higher.

When it was approved in March 2024, Rezdiffra became the only medicine approved by the Food and Drug Administration (FDA) to ...

It's worth noting that other billionaire investors were buying Apple shares in Q3, including Ole Andreas Halvorsen of Viking ...

Amazon's shares currently have a price-to-earnings ratio of 43, compared to 27 for Home Depot. That makes Home Depot ...

Bill Ackman is a billionaire nine times over, according to Forbes. He made his vast wealth by running Pershing Square Capital ...

As the rising star of cell therapy biotechs, Iovance Biotherapeutics ( IOVA 3.76%) is a hot stock that's capturing a lot of ...

From the end of 2022 through Nov. 19, the benchmark S&P 500 index rose a stunning 54.1%. As is often the case during bull ...